Your session is about to expire
← Back to Search
Radiofrequency Ablation for Breast Cancer (ABLATE Trial)
ABLATE Trial Summary
This trial will study whether using radiofrequency ablation to extend the "final" negative margin on breast cancer lumpectomy sites can decrease the rates of re-operation.
ABLATE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowABLATE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ABLATE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My breast cancer is invasive lobular carcinoma.I am younger than 50 years old.I am a woman aged 50 or older.My tumor is larger than 3 cm.I have cancer in both sides of a paired organ.My tumor is located in one area and on one side of my body.My cancer affects the skin.My lymph nodes are enlarged or abnormal.I was diagnosed with breast cancer less than 2 years ago and it has not returned.I have had chemotherapy for breast cancer within the last two years.My breast cancer is hormone receptor positive.My tumor is 3 cm or smaller.I am male.You have breast implants.My tumor does not affect the skin.My breast cancer is confirmed as DCIS or IDC, grade I-III.
- Group 1: Surgery followed by RFA
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there opportunities for new patients to join this trial?
"Unfortunately, this particular clinical trial is not presently recruiting patients. Although this clinical trial is not enrolling patients anymore, there are 2683 other clinical trials currently accepting patients at this time."
Does this research involve any volunteers who are octogenarians or older?
"In order to participate in this clinical trial, applicants must between the ages of 50 and 100. Out of the 3,661 total trials, this study is one of 74 trials for patients under the age of 18 and one of 2587 for people over 65."
Are there any prerequisites for enrolling in this clinical trial?
"104 women with breast cancer will be enrolled in this study. The requirements for participants are as follows: The patient must be a female aged 50 or 100, the tumor size must be 3 cm or less, the tumor must be unilateral and not involving the skin, pathology must confirm ductal in situ or infiltrating ductal carcinoma of grade I-III, if the tumor is IDC, it must be hormone receptor positive, the patient must sign written informed consent and HIPAA forms."
Share this study with friends
Copy Link
Messenger